Literature DB >> 4704100

Report of vascilitis and blindness after intracarotid injection of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) in dogs.

W D DeWys, E H Fowler.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4704100

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN: 0069-0112


× No keyword cloud information.
  7 in total

1.  Intracarotid infusion of PCNU (NSC: 95466): preclinical toxicological study in dogs.

Authors:  L Goumnerova; M T Richard; D Addison; V Montpetit; D J Stewart
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

Review 2.  Interstitial chemotherapy for brain tumors: review.

Authors:  T Tomita
Journal:  J Neurooncol       Date:  1991-02       Impact factor: 4.130

3.  In vivo measurement of tumor blood oxygenation by near-infrared spectroscopy: immediate effects of pentobarbital overdose or carmustine treatment.

Authors:  R G Steen; K Kitagishi; K Morgan
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

4.  Superselective intracerebral chemotherapy of malignant tumours with BCNU. Neuroradiological considerations.

Authors:  J Théron; J G Villemure; C Worthington; J L Tyler
Journal:  Neuroradiology       Date:  1986       Impact factor: 2.804

5.  Central neurotoxicity following intracarotid BCNU chemotherapy for malignant gliomas.

Authors:  M S Mahaley; R A Whaley; M Blue; L Bertsch
Journal:  J Neurooncol       Date:  1986       Impact factor: 4.130

6.  Visual toxicity following intra-arterial chemotherapy with hydroxyethyl-CNU in patients with malignant gliomas. A prospective study with statistical analysis.

Authors:  G Defer; F Fauchon; M Schaison; J Chiras; P Brunet
Journal:  Neuroradiology       Date:  1991       Impact factor: 2.804

7.  Fatal necrotizing encephalopathy complicating treatment of malignant gliomas with intra-arterial BCNU and irradiation: a pathological study.

Authors:  M K Rosenblum; J Y Delattre; R W Walker; W R Shapiro
Journal:  J Neurooncol       Date:  1989-09       Impact factor: 4.130

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.